No Detail Found!

Antibiotic resistance in MRSA: Exploring alternative treatment options through linezolid and daptomycin

Author(s)
Ramsha Iqbal Lahore Garrison University,Sector C, DHA Phase 6, Lahore,Pakistan
Amna Gulzar Lahore Garrison University,Sector C, DHA Phase 6, Lahore,Pakistan
Humaira Niamat Lahore Garrison University,Sector C, DHA Phase 6, Lahore,Pakistan
Abstract
Methicillin-Resistant Staphylococcus aureus (MRSA) infections became difficult to cure as they expanded over the world. As, Staphylococcus aureus can cause a variety of illnesses in the body, MRSA infections, in particular, can be acquired in healthcare settings (HA-MRSA) and community settings (CA-MRSA). MRSA infections have been demonstrated to be resistant to penicillin, -lactam, and vancomycin, as well as other antimicrobials, restricting their treatment choices. Their susceptibility testing was examined using morphological, molecular, and new methodologies. Because it was resistant to numerous antibiotics, it was important to develop new agents for therapy; this article covers the current use of antibiotics, which include linezolid and daptomycin. This article discusses the mechanism of action, antibacterial activity, clinical perspectives, resistance, and side effects of the antibiotics: linezolid and daptomycin. Different antibiotics were tested in various parts of the world, and the results revealed that practically all antibiotics are resistant to MRSA infections, with linezolid and daptomycin in particular showing resistance at a very low ratio. As a result, linezolid and daptomycin are preferred for treatment; the following article also discusses their benefits and drawbacks for humans. Similarly, it focused on the developing threats to linezolid and daptomycin antibiotics. Combination therapy should be considered for the decrease of resistance to these antibiotics. The present paper seeks to provide a current and up-to-date review of antibiotic susceptibility testing for MRSA.
Publication Details
Page(s) 1-7
Published Journal: Abasyn Journal of Life Sciences, Volume: 6, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
linezolid, Antibiotics resistance, Antibiotic susceptibility testing, Daptomycin, MRSA infections
References
Rağbetli C,Parlak M,Bayram Y,Guducuoglu H,Ceylan N. .2016 .Evaluation of antimicrobial resistance in Staphylococcus aureus isolates by years. 2016 May, 9 : .
Foster T.,Staphylococcus T. .1996 .. Medical Microbiology. 4th edition, : .
'Gara JP O .2007 .ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS microbiology letters, 270(2) : 179-88.
Lee E,Anjum F .2022 .Staphylococcus epidermidis. , : .
Vuong C,Otto M. .2002 .Staphylococcus epidermidis infections. Microbes and infection, 4(4) : 481-9.
MJNrm Otto .2009 .Staphylococcus epidermidis-the'accidental'pathogen. , 7(8) : 555-67.
Hellmark B,Unemo M,Nilsdotter-Augustinsson Å,Söderquist B .2009 .Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. Clinical microbiology and infection, 15(3) : 238-44.
Ehlers S,Merrill SA .2018 .. , : .
Raz R,Colodner R,Kunin CM .2005 .Who are you-Staphylococcus saprophyticus?. Clinical Infectious Diseases, 40(6) : 896-8.
Hashemzadeh M,Dezfuli AA,Nashibi R,Jahangirimehr F,Akbarian ZA .2021 .Study of biofilm formation, structure and antibiotic resistance in Staphylococcus saprophyticus strains causing urinary tract infection in women in Ahvaz, Iran. , 39 : 100831.
Turner NA,Sharma-Kuinkel BK,Maskarinec SA,Eichenberger EM,Shah PP,Carugati M,Holland TL .2019 .Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nature Reviews Microbiology, 17(4) : 203-18.
Boucher HW,Corey GR .2008 .Epidemiology of methicillin-resistant Staphylococcus aureus. Clinical infectious diseases, 46(Supplement) : S344-S9.
Rayner C,Munckhof WJ .2005 .Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus. Internal medicine journal, 35 : S3-16.
Foster TJ .2019 .Can β-lactam antibiotics be resurrected to combat MRSA?. , 27(1) : 26-38.
Lundstrom TS,Sobel JD .2004 .Antibiotics for gram-positive bacterial infections: vancomycin, quinupristindalfopristin, linezolid, and daptomycin. Infectious Disease Clinics, 18(3) : 651-68.
Hiramatsu K. .2001 .Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. The Lancet infectious diseases, 1(3) : 147-55.
Pennsylvania .2002 .17 Centers for Disease Control and Prevention (CDC. Vancomycin-resistant Staphylococcus aureus-. Morbidity and mortality weekly report, 51(40) : 902.
Appelbaum PC .2006 .The emergence of vancomycin‐intermediate and vancomycin‐resistant Staphylococcus aureus. Clinical Microbiology and Infection, 12 : 16-23.
Micek ST .2007 .Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clinical infectious diseases, 45(Supplement) : S184-S90.
Bal AM,David MZ,Garau J,Gottlieb T,Mazzei T,Scaglione F,Tattevin P,Gould IM .2017 .Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen. Journal of global antimicrobial resistance, 10 : 295-303.
Zahedi Bialvaei A,Rahbar M,Yousefi M,Asgharzadeh M,Samadi Kafil H. Linezolid M .2017 .: a promising option in the treatment of Gram-positives. 2017 Feb, 72(2) : 354-64.
Stevens DL,Dotter B,Madaras-Kelly K B .2004 .A review of linezolid: the first oxazolidinone antibiotic. Expert review of anti-infective therapy. , 2(1) : 51-9.
Nannini E,Murray BE .2010 .Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. , 10(5) : 516-21.
Iqbal .2023 .. , : .
Miller WR,Bayer AS .2016 .Mechanism of action and resistance to daptomycin in Staphylococcus aureus and enterococci. , 6(11) : a026997.
Heidary M,Khosravi AD,Khoshnood S,Nasiri MJ,Soleimani S .2018 .. , 73(1) : 1-11.
Bellido JL .2017 .Mechanisms of resistance to daptomycin in Staphylococcus aureus. Rev. Esp. Quimioter, 30 : 391-6.
Hayden MK,Rezai K,Hayes RA,Lolans K,Quinn JP,Weinstein RA .2005 .Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. Journal of clinical microbiology, 43(10) : 5285-7.
Aktas G,Derbentli S. .2017 .To read the copy of this license please visit: https://creativecommons. Journal of Antimicrobial Chemotherapy, 72(2) : 441-3.
0

Citations

0

Downloads

42

Views